France 2030
Overview
France 2030 is a French national strategic investment plan managed by the Secrétariat Général pour l'Investissement (SGPI) that provides funding, grants, and equity investments to support industrial innovation, decarbonization, and emerging technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lattice Medical | Jul 2026 | Grant | Co-investor |
| LITE Therapeutics | - | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is France 2030 based?
France 2030 is headquartered in Paris, France.
When was France 2030 founded?
France 2030 was founded in 2021.
How many portfolio companies does France 2030 have?
France 2030 has 2 portfolio companies in Caplight's dataset.
What are some companies in France 2030's portfolio?
Recent investments visible on Caplight include Lattice Medical, Lattice Medical, LITE Therapeutics.
What was France 2030's most recent investment?
France 2030's most recent investment on Caplight was in Lattice Medical in 2026.
What sectors does France 2030 focus on?
France 2030 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does France 2030 focus on?
Stage focus information for France 2030 is not publicly available.
What is France 2030's AUM?
France 2030's assets under management are estimated between $58.3B and $58.3B.